Minnesota SF 2841: Drug manufacturer or wholesale drug distributor price gouging prohibition; board of pharmacy, commissioner of human services and health plan companies notification of prescription drug increases to attorney general authorization; attorney general access to drug pricing information and authorization to take action against drug manufacturers and wholesalers related to certain price increases establishment

Status: Referred to Health and Human Services Finance and Policy (as of 2018-03-01)

State: Minnesota · Session: 2017-2018 · Bill: SF 2841

Subjects: Courts, Drugs and Medicine, Health and Health Department, Human Services and Human Services Department, Insurance-Health, Legal Proceedings

Sponsors: Klein, Jensen, Lourey

View Minnesota SF 2841 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.